Trimix: The ED Treatment Most Men Have Never Heard Of

By Dr. Meyer Schoeman, MD — Precision Sexual Health Clinic, Calgary

If you’ve tried sildenafil or tadalafil and haven’t gotten the results you were hoping for, there is a highly effective second-line treatment that most men have never been told about. It has a response rate significantly higher than oral therapy, works regardless of the nitric oxide pathway, and produces reliable erections in men who have failed every PDE-5 inhibitor on the market.

It’s called Trimix. And the main reason more men don’t know about it is that it involves self-injection — which sounds worse than it is.

What Trimix Is

Trimix is a compounded intracavernosal injection containing three vasoactive agents: alprostadil (prostaglandin E1), phentolamine (an alpha-adrenergic antagonist), and papaverine (a non-selective phosphodiesterase inhibitor). Each component contributes a different mechanism of smooth muscle relaxation in the corpus cavernosum. Together, they produce synergistic vasodilation and tumescence that does not depend on sexual stimulation triggering the nitric oxide cascade.

This is the critical distinction from oral PDE-5 inhibitors. Sildenafil and tadalafil support cavernosal smooth-muscle relaxation in response to sexual stimulation, while Trimix delivers vasoactive medications directly into the corpus cavernosum. This direct local action helps explain why intracavernosal therapy may work for men who have not responded adequately to oral treatment, including some patients with severe vascular disease, diabetes-related ED, or ED following prostate surgery. Canadian clinical guidance recognizes intracavernosal injections as an effective second-line therapy, and a recent study reported satisfactory erectile function in 85% of PDE-5 inhibitor-resistant post-prostatectomy patients treated with Trimix.

How To Use Trimix

Trimix is injected into the lateral aspect of the corpus cavernosum using a fine-gauge needle — typically 27 or 29 gauge — immediately before sexual activity. The injection site is the lateral penile shaft, avoiding the urethra, dorsal vessels, and nerves. With proper technique, most men describe the injection as minimally uncomfortable — significantly less than they anticipated.

The onset of action is typically five to fifteen minutes. The formulation is compounded to the individual patient — dose and concentration are adjusted based on response during an in-clinic titration visit, where the physician administers the first injection under observation and monitors the erectile response. This visit is important both for dosing precision and for patient education on self-injection technique.

Trimix requires refrigeration and has a limited shelf life once compounded. These are practical considerations, not obstacles — most men manage them without difficulty once they’ve been properly counselled.

Who It’s For

The primary candidates for Trimix are men with moderate-to-severe vasculogenic ED who have not responded adequately to oral PDE-5 inhibitors, men with post-radical prostatectomy ED where nerve recovery is incomplete, men with significant neuropathic ED from diabetes or spinal cord injury, and men who have contraindications to PDE-5 inhibitors — most commonly those on nitrate medications.

It is also appropriate for men who have responded partially to oral therapy but want more reliable and consistent results. The degree of control that intracavernosal injection provides — predictable onset, predictable rigidity, consistent response — is something oral therapy rarely matches.

The Risks and How They’re Managed

The most clinically significant risk of intracavernosal injection therapy is priapism — a prolonged erection beyond four hours. This is why dose titration under physician supervision is essential: the goal is to identify the lowest effective dose that produces a satisfactory erection without excessive duration. Men are counselled on the signs of prolonged erection and on the protocol for managing it if it occurs.

Other potential adverse effects include injection site bruising, penile pain, and, with long-term use, corporal fibrosis at injection sites — which is minimised by rotating injection sites and using proper technique. Systemic effects are rare because the medication acts locally.

Doctor explaining Trimix injection therapy in Calgary Trimix injection therapy for Erectile dysfunction in Alberta Safe ED treatment in Calgary

The ED Treatment Conversation Worth Having

Most men who are ultimately prescribed Trimix wish they’d known about it sooner. The self-injection component creates psychological resistance that dissolves quickly once men experience the results. A treatment that works reliably, on demand, without depending on the unpredictable pharmacokinetics of an oral drug taken an hour before — that’s a meaningful quality-of-life difference.

If you’ve been managing ED with oral therapy that isn’t working well, or if you’ve been told there’s nothing else to try, Trimix is a conversation worth having with a physician who offers it.

Take the first step and book a consultation at Precision Clinic Calgary today.

Dr. Meyer Schoeman is the founder of Precision Sexual Health Clinic for Men in Calgary, offering Trimix intracavernosal injection therapy with in-clinic titration and patient education. Book a consultation at precisioncliniccalgary.ca.